Back to Trades
Stetz Gary S.
Interim CEODirectorCIK 0001532793
Total Volume
$821.5K
6 filings
Purchases
$150.0K
2 buy txns
Sales
$343.9K
8 sell txns
Net Activity
-$193.9K
net sold
Profile
- Filings
- 6
- Buy transactions
- 2
- Sell transactions
- 8
- Companies
- 2
- Active
- 2025–2026
Stetz Gary S., Interim CEO, Director, accounts for 6 disclosed filings worth $821.5K, spread across 2 companies, active 2025–2026. The record is net selling, with $150.0K in purchases against $343.9K in sales. The largest single open-market purchase on record is $100.0K in Hepion Pharmaceuticals, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO, Director | Award | $107.6K |
| Aug 12 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO, Director | Buy | $100.0K |
| May 27 | CNTN Canton Strategic Holdings, Inc. | Stetz Gary S. | Director | Sell | $343.9K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO, Director | Buy | $50.0K |
| Nov 5 | THAR Tharimmune, Inc. | Stetz Gary S. | Director | Award | $99.9K |
| Aug 20 | THAR Tharimmune, Inc. | Stetz Gary S. | Director | Other | $0 |
6 filings